
Loading, please wait...

Loading, please wait...

Ulcerative colitis monitoring traditionally relies on invasive procedures like colonoscopy. However, recent advancements in digital health now offer patient-reported outcome measures (PROMs) as a potential alternative. At Haukeland University Hospital, researchers evaluated the Mobile Health Index for Ulcerative Colitis (MHI-UC) to determine its effectiveness. This tool aims to detect disease activity without the immediate need for endoscopy.
The primary objective of this retrospective study was to compare the MHI-UC with the endoscopic Mayo score (e-MAYO). Researchers analyzed a Norwegian cohort of patients who completed the digital index within four weeks of their endoscopic evaluation. Consequently, the results showed a strong correlation of 0.64 between the two methods. For patients with an e-MAYO score greater than zero, the correlation increased significantly to 0.78.
Furthermore, the MHI-UC proved highly accurate in identifying moderate to severe disease activity. Patients who required clinical interventions, such as treatment changes or referrals, presented with significantly higher MHI-UC scores. Specifically, those needing intervention had an average score of 4.3, compared to just 2.3 in stable patients. This suggests that the index can effectively guide clinical decision-making by flagging patients at risk of flare-ups.
Improving
The MHI-UC is a patient-reported outcome measure used via mobile health platforms. It assesses symptoms such as stool frequency, rectal bleeding, and abdominal pain to determine disease activity levels in ulcerative colitis patients.
While MHI-UC shows a high correlation with endoscopic scores, it currently acts as a complementary tool. It helps identify patients who require urgent endoscopic assessment or treatment adjustments rather than replacing the gold-standard visualization entirely.
The study demonstrated that MHI-UC has high accuracy in detecting moderate to severe disease activity. It also reflects changes in endoscopic activity when patients undergo treatment modifications.
Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Sommervoll FÅ et al. Comparison of endoscopy and mobile health index for ulcerative colitis. Scand J Gastroenterol. 2026 Mar 25. doi: 10.1080/00365521.2026.2645085. PMID: 41878872.
Turner D et al. Patient-reported outcomes in ulcerative colitis. Cochrane Database Syst Rev. 2022.
Bodger K et al. Development and validation of the IBD-Control questionnaire. Gut. 2014.
"
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A study comparing MHI-UC with endoscopic Mayo scores shows high accuracy in detecting moderate-to-severe disease activity, potentially reducing endoscopy ne...
6 months ago

A breakthrough study evaluated H5N1 transmission efficiency across mammalian isolates. Researchers discovered that human-derived D1.1 harboring the PB2 D701N mutation spread efficiently in ferrets, unlike strains carrying PB2 E627K. This finding highlights critical genetic markers for zoonotic surveillance.
Today

A comparative cohort study evaluates vNOTES vs TLH hysterectomy for benign conditions, demonstrating shorter operative duration, faster return to daily activities, and equivalent female sexual function scores without increased dyspareunia.
Today

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Yesterday

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Yesterday

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today